Atopic Dermatitis and the Stratum Corneum: Part 1: the Role of Filaggrin in the Stratum Corneum Barrier and Atopic Skin

Overview

Journal J Clin Aesthet Dermatol

Date 2013 Oct 25

PMID 24155988

Citations 16

Authors

Jacquelyn Levin

Sheila Fallon Friedlander

James Q Del Rosso

Affiliations

Soon will be listed here.

Abstract

This three-part review presents what is currently known about the involvement and interdependency of the barrier properties of the epidermis, especially the stratum corneum and various specific immunological responses in the etiopathogenesis of atopic dermatitis. Part 1 of this review depicts the role of filaggrin in atopic dermatitis while Part 2 (which will be published in an upcoming issue of The Journal of Clinical and Aesthetic Dermatology) evaluates the role of serine proteases and specific lipids in the structural and functional integrity of the stratum corneum and related barrier functions in atopic dermatitis. Filaggrin is a key component of the stratum corneum that is derived from a larger precursor protein and contributes to its physical strength, hydration status, skin pH, and buffering capacity among other physiochemical properties. Filaggrin gene loss of function mutations appear to play a pathophysiological role; however, they are not the sole pathogenic factor in atopic dermatitis. Adverse structural changes of the stratum corneum are caused by upregulation of serine proteases activity, which causes degradation of certain stratum corneum proteins that are integral to barrier functions; interference with the formation of the stratum corneum intercellular lipid membrane, which normally regulates epidermal water flux and gradient; and induction of a TH2 pattern of inflammation, which is characteristic of atopic skin. Alteration in lipid ratios and changes in lipid-directed enzymes may play a role in the impairment of epidermal barrier functions that are associated with atopic dermatitis. Part 3 of this review (which will be published in an upcoming issue of The Journal of Clinical and Aesthetic Dermatology) discusses how immune dysregulation, including upregulation of a TH2 inflammation pattern, augmented allergic sensitization, sustained wound healing inflammation, and impaired innate immunity all play a role in the development of atopic dermatitis. An increased understanding of the interdependence, polymorphisms, and dysregulations of epidermal barrier functions, including the stratum corneum permeability barrier, immune response barrier, and antimicrobial barrier, should provide further knowledge about the pathophysiological mechanisms that are related to the development of atopic dermatitis, are clinically relevant, and can better direct researchers to develop therapies that are targeted at important pathogenic components of the disease state.

Citing Articles

Skin 101: Understanding the Fundamentals of Skin Barrier Physiology-Why is This Important for Clinicians?.

Del Rosso J, Kircik L J Clin Aesthet Dermatol. 2025; 18(2):7-15.

PMID: 40078856 PMC: 11896616.

Identification of senescence rejuvenation mechanism of extract including honokiol as a core ingredient.

Lee Y, Jeong E, Kim Y, Park J, Yoon J, Lee Y Aging (Albany NY). 2025; 17(2):497-523.

PMID: 39992207 PMC: 11892931. DOI: 10.18632/aging.206207.

Transcriptional Profiling of during the Transition from Asymptomatic Nasal Colonization to Skin Colonization/Infection in Patients with Atopic Dermatitis.

Li P, Schulte J, Wurpts G, Hornef M, Wolz C, Yazdi A Int J Mol Sci. 2024; 25(17).

PMID: 39273114 PMC: 11394835. DOI: 10.3390/ijms25179165.

Atopic Dermatitis: Molecular Alterations between Lesional and Non-Lesional Skin Determined Noninvasively by In Vivo Confocal Raman Microspectroscopy.

Zolotas M, Schleusener J, Lademann J, Meinke M, Kokolakis G, Darvin M Int J Mol Sci. 2023; 24(19).

PMID: 37834083 PMC: 10572245. DOI: 10.3390/ijms241914636.

Molluscum Contagiosum: Epidemiology, Considerations, Treatment Options, and Therapeutic Gaps.

Hebert A, Bhatia N, Del Rosso J J Clin Aesthet Dermatol. 2023; 16(8 Suppl 1):S4-S11.

PMID: 37636018 PMC: 10453394.

References

Leyden J, MARPLES R, Kligman A . Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol. 1974; 90(5):525-30. DOI: 10.1111/j.1365-2133.1974.tb06447.x. View

Zutavern A, Hirsch T, Leupold W, Weiland S, Keil U, von Mutius E . Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: results from a cross-sectional study. Clin Exp Allergy. 2005; 35(10):1301-8. DOI: 10.1111/j.1365-2222.2005.02350.x. View

Akiyama M . FLG mutations in ichthyosis vulgaris and atopic eczema: spectrum of mutations and population genetics. Br J Dermatol. 2009; 162(3):472-7. DOI: 10.1111/j.1365-2133.2009.09582.x. View

Hachem J, Man M, Crumrine D, Uchida Y, Brown B, Rogiers V . Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol. 2005; 125(3):510-20. DOI: 10.1111/j.0022-202X.2005.23838.x. View

Irvine A . Fleshing out filaggrin phenotypes. J Invest Dermatol. 2007; 127(3):504-7. DOI: 10.1038/sj.jid.5700695. View

Kezic S, Kemperman P, Koster E, de Jongh C, Thio H, Campbell L . Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol. 2008; 128(8):2117-9. DOI: 10.1038/jid.2008.29. View

ORegan G, Sandilands A, McLean W, Irvine A . Filaggrin in atopic dermatitis. J Allergy Clin Immunol. 2008; 122(4):689-693. DOI: 10.1016/j.jaci.2008.08.002. View

Fallon P, Sasaki T, Sandilands A, Campbell L, Saunders S, Mangan N . A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet. 2009; 41(5):602-8. PMC: 2872154. DOI: 10.1038/ng.358. View

Miajlovic H, Fallon P, Irvine A, Foster T . Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol. 2010; 126(6):1184-90.e3. PMC: 3627960. DOI: 10.1016/j.jaci.2010.09.015. View

10.

ORegan G, Irvine A . The role of filaggrin in the atopic diathesis. Clin Exp Allergy. 2010; 40(7):965-72. DOI: 10.1111/j.1365-2222.2010.03522.x. View

11.

Rodriguez E, Baurecht H, Herberich E, Wagenpfeil S, Brown S, Cordell H . Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol. 2009; 123(6):1361-70.e7. DOI: 10.1016/j.jaci.2009.03.036. View

12.

Presland R, Boggess D, Lewis S, Hull C, Fleckman P, Sundberg J . Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol. 2000; 115(6):1072-81. DOI: 10.1046/j.1523-1747.2000.00178.x. View

13.

Eberlein-Konig B, Schafer T, Huss-Marp J, Darsow U, Mohrenschlager M, Herbert O . Skin surface pH, stratum corneum hydration, trans-epidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children. Acta Derm Venereol. 2000; 80(3):188-91. DOI: 10.1080/000155500750042943. View

14.

Elias P, Schmuth M . Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol. 2009; 9(5):437-46. PMC: 2852024. DOI: 10.1097/ACI.0b013e32832e7d36. View

15.

Hachem J, Crumrine D, Fluhr J, Brown B, Feingold K, Elias P . pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol. 2003; 121(2):345-53. DOI: 10.1046/j.1523-1747.2003.12365.x. View

16.

Baurecht H, Irvine A, Novak N, Illig T, Buhler B, Ring J . Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol. 2007; 120(6):1406-12. DOI: 10.1016/j.jaci.2007.08.067. View

17.

Fluhr J, Kao J, Jain M, Ahn S, Feingold K, Elias P . Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol. 2001; 117(1):44-51. DOI: 10.1046/j.0022-202x.2001.01399.x. View

18.

Choi M, Maibach H . Role of ceramides in barrier function of healthy and diseased skin. Am J Clin Dermatol. 2005; 6(4):215-23. DOI: 10.2165/00128071-200506040-00002. View

19.

Irvine A, McLean W . Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol. 2006; 126(6):1200-2. DOI: 10.1038/sj.jid.5700365. View

20.

Hauser C, Wuethrich B, Matter L, Wilhelm J, SONNABEND W, Schopfer K . Staphylococcus aureus skin colonization in atopic dermatitis patients. Dermatologica. 1985; 170(1):35-9. View